Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.

Witt DM, Delate T, Hylek EM, Clark NP, Crowther MA, Dentali F, Ageno W, Martinez KD, Garcia DA.

Thromb Res. 2013;132(6):770-5. doi: 10.1016/j.thromres.2013.10.024. Epub 2013 Oct 17.

PMID:
24521790
2.

Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.

Mantha S, Pianka AM, Tsapatsaris N.

J Thromb Thrombolysis. 2011 Oct;32(3):334-42. doi: 10.1007/s11239-011-0609-2.

PMID:
21674132
3.

Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study.

Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network.

Can J Cardiol. 2012 Jan-Feb;28(1):33-9. doi: 10.1016/j.cjca.2011.10.002. Epub 2011 Dec 7.

PMID:
22153256
4.

Use of blood products in patients with anticoagulant-related major bleeding: an analysis of inhospital outcomes.

Menzin J, Sussman M, Nichols C, Friedman M, Zbrozek A.

Am J Health Syst Pharm. 2014 Oct 1;71(19):1635-45. doi: 10.2146/ajhp130729.

PMID:
25225449
5.

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

Ann Intern Med. 2004 Nov 16;141(10):745-52.

PMID:
15545674
6.

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.

Nielsen PB, Larsen TB, Skjøth F, Lip GY.

JAMA Intern Med. 2017 Apr 1;177(4):563-570. doi: 10.1001/jamainternmed.2016.9369.

PMID:
28241151
7.

Antithrombotic drugs and risk of hemorrhagic stroke in the general population.

García-Rodríguez LA, Gaist D, Morton J, Cookson C, González-Pérez A.

Neurology. 2013 Aug 6;81(6):566-74. doi: 10.1212/WNL.0b013e31829e6ffa. Epub 2013 Jul 10.

PMID:
23843464
8.

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.

Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE.

J Am Geriatr Soc. 2006 Aug;54(8):1231-6.

10.

Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.

Curtze S, Strbian D, Meretoja A, Putaala J, Eriksson H, Haapaniemi E, Mustanoja S, Sairanen T, Satopää J, Silvennoinen H, Niemelä M, Kaste M, Tatlisumak T.

Eur J Neurol. 2014 Apr;21(4):616-22. doi: 10.1111/ene.12352. Epub 2014 Jan 21.

PMID:
24447727
11.

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.

Vestergaard AS, Skjøth F, Lip GY, Larsen TB.

Stroke. 2016 Apr;47(4):979-85. doi: 10.1161/STROKEAHA.115.012338. Epub 2016 Feb 16.

12.

Nonadherence with INR monitoring and anticoagulant complications.

Witt DM, Delate T, Clark NP, Garcia DA, Hylek EM, Ageno W, Dentali F, Crowther MA.

Thromb Res. 2013 Aug;132(2):e124-30. doi: 10.1016/j.thromres.2013.06.006. Epub 2013 Jun 22.

PMID:
23800635
13.

Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.

Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W.

J Am Coll Cardiol. 2007 Jul 24;50(4):309-15. Epub 2007 Jul 6.

14.

Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.

Menzin J, Hoesche J, Friedman M, Nichols C, Bergman GE, Crowther M, Garcia D, Jones C.

J Thromb Haemost. 2012 Apr;10(4):596-605. doi: 10.1111/j.1538-7836.2012.04636.x.

15.

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.

Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC.

Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.

PMID:
28356246
16.
17.

Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.

Witt DM, Clark NP, Martinez K, Schroeder A, Garcia D, Crowther MA, Ageno W, Dentali F, Ye X, Hylek E, Delate T.

Thromb Res. 2015 Nov;136(5):1040-4. doi: 10.1016/j.thromres.2015.10.002. Epub 2015 Oct 9.

PMID:
26454758
18.

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.

N Engl J Med. 2003 Sep 11;349(11):1019-26.

19.

Intracranial hemorrhages related with warfarin use and comparison of warfarin and acetylsalicylic acid.

Seçil Y, Ciftçi Y, Tokuçoğlu F, Beckmann Y.

J Stroke Cerebrovasc Dis. 2014 Feb;23(2):321-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.008. Epub 2013 Apr 4.

PMID:
23562210
20.

Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage.

Chu C, Tokumaru S, Izumi K, Nakagawa K.

Int J Neurosci. 2016;126(1):62-6. doi: 10.3109/00207454.2014.993034. Epub 2014 Dec 27.

PMID:
25430740

Supplemental Content

Support Center